NEW YORK – AbCellera Biologics said on Friday that it has filed a patent infringement lawsuit against Berkeley Lights in the United States District Court for the District of Delaware.
AbCellera claims that Berkeley Lights is infringing on eights of its patents — US Patent Nos. 10,107,812; 10,274,494; 10,466,241; 10,578,618; 10,697,962; 10,087,408; 10,421,936; and 10,704,018 — which cover AbCellera's proprietary platforms directed to the use of microfluidics for single-cell antibody discovery, cell clone culture and selection, and genomic sequencing using nanoliter-volume chambers.